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RESEARCH ARTICLE
Limonene and its ozone-initiated reaction products attenuate allergic lung
inflammation in mice
Jitka S. Hansena, Asger W. Nørgaarda, Ismo K. Koponena, Jorid B. Sørlia, Maya D. Paidia, Søren W. K. Hansenb,
Per Axel Clausena, Gunnar D. Nielsena, Peder Wolkoffa and Søren Thor Larsena
aThe National Research Centre for the Working Environment, Copenhagen, Denmark; bInstitute of Molecular Medicine, University of Southern
Denmark, Odense, Denmark
ABSTRACT
Inhalation of indoor air pollutants may cause airway irritation and inflammation and is suspected to worsen
allergic reactions. Inflammation may be due to mucosal damage, upper (sensory) and lower (pulmonary)
airway irritation due to activation of the trigeminal and vagal nerves, respectively, and to neurogenic
inflammation. The terpene, d-limonene, is used as a fragrance in numerous consumer products. When lim-
onene reacts with the pulmonary irritant ozone, a complex mixture of gas and particle phase products is
formed, which causes sensory irritation. This study investigated whether limonene, ozone or the reaction
mixture can exacerbate allergic lung inflammation and whether airway irritation is enhanced in allergic
BALB/cJ mice. Na€ıve and allergic (ovalbumin sensitized) mice were exposed via inhalation for three con-
secutive days to clean air, ozone, limonene or an ozone–limonene reaction mixture. Sensory and pulmon-
ary irritation was investigated in addition to ovalbumin-specific antibodies, inflammatory cells, total protein
and surfactant protein D in bronchoalveolar lavage fluid and hemeoxygenase-1 and cytokines in lung tis-
sue. Overall, airway allergy was not exacerbated by any of the exposures. In contrast, it was found that lim-
onene and the ozone–limonene reaction mixture reduced allergic inflammation possibly due to antioxidant
properties. Ozone induced sensory irritation in both na€ıve and allergic mice. However, allergic but not
na€ıve mice were protected from pulmonary irritation induced by ozone. This study showed that irritation
responses might be modulated by airway allergy. However, aggravation of allergic symptoms was observed
by neither exposure to ozone nor exposure to ozone-initiated limonene reaction products. In contrast, anti-
inflammatory properties of the tested limonene-containing pollutants might attenuate airway allergy.
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Introduction
Asthma is characterized by the presence of airway inflammation,
mucus hypersecretion, airway remodeling and airway hyper-
responsiveness leading to airflow limitation (Lambrecht &
Hammad 2015). Persons suffering from asthma and allergic air-
way disease may be more sensitive to inhaled irritants because of
these airway abnormalities. For example, cold air-induced asthma
attacks may be caused by the stimulation of receptors on the
vagus nerves, which activate bronchial smooth muscles (Xing
et al. 2008). Further, trigeminal neuronal hyper-responsiveness
has been observed in allergic inflammation (Canning 2002).
Another observation is that prostaglandin E2 released during
inflammatory reactions enhances the sensitivity of pulmonary C-
fibers to sensory irritants (Lee & Widdicombe 2001). Inhalation
of reactive volatile organic compounds (VOC) and particles pre-
sent in the indoor environment can per se cause airway inflamma-
tion and irritation (Wolkoff et al. 2013). This may be due to
direct mucosal damage, upper (sensory) and lower (pulmonary)
airway irritation due to activation of the trigeminal and the vagal
nerves, respectively, and neurogenic inflammation. However, the
reaction to inhalation of irritant VOC or particles is not well elu-
cidated in persons with allergic airway inflammation.
Indoor air pollutants can contain complex mixtures of VOC
emitted from paints, furniture, cleaning agents and fabrics. Several
studies have suggested that outdoor pollutants may exacerbate
asthma (Carlsten & Melen 2012; Huang et al. 2015; Thurston et al.
1997), but the causality between exacerbation and exposure to irri-
tants and pollutants in indoor air is yet unsupported (Nurmatov
et al. 2015). Ozone is an indoor air pollutant; it infiltrates from the
outdoors and is emitted from high-voltage electrical appliances.
Ozone causes pulmonary irritation (Nielsen et al. 1999) and triggers
pulmonary responses (Johansson et al. 2015; Silverman & Ito
2010). Generally, indoor ozone concentrations are between 20%
and 70% of outdoor levels. Reported indoor levels are between 2
and 100 ppb, but substantially higher levels in aircrafts (Fadeyi
2015). Epidemiological studies have described associations between
asthma attacks and high levels of air pollution, including ozone
(Peel et al. 2005; Silverman & Ito 2010).
The terpene, limonene, a ubiquitous indoor VOC, is used as a
fragrance in consumer and household products (Nazaroff &
Weschler 2004). Reported concentrations are from 10–100 ppb in
air cabins and offices (Nørgaard et al. 2014), but peak exposures
may be considerably higher (Trantalidi et al. 2015). When limon-
ene reacts with and thus consumes ozone, a complex reaction
mixture of (poly)-oxygenated VOC and ultrafine particles (sec-
ondary organic aerosols) is formed that causes upper airway irri-
tation (Rohr et al. 2002; Wolkoff et al. 2008, 2012).
Based on the above findings, it was hypothesized that inhal-
ation of ozone and of ozone-initiated limonene reaction products
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aggravate allergic airway disease, including inflammation. Further,
it was hypothesized that the effect of inhaled airway irritants is
exacerbated in the presence of an allergic lung inflammation. A
few studies have demonstrated an anti-inflammatory prophylactic
effect of limonene alone using rodent models of allergic inflam-
mation (Bibi et al. 2015; Hirota et al. 2012; Hansen et al. 2013;
Keinan et al. 2005). Thus, it was further hypothesized that inhal-
ation of limonene could attenuate an existing allergic airway
inflammation and thus possess a treatment-related effect.
To address the hypotheses, allergic and nonallergic mice were
exposed to air alone, ozone, limonene or an ozone–limonene
reaction mixture. By using a factorial design, where allergic and non-
allergic animals were exposed to the same air pollutants, it was pos-
sible to investigate if: (a) limonene, ozone, or their reaction products
caused acute effects on respiration and inflammation in non-allergic
mice; (b) limonene, ozone or their reaction products aggravated or
attenuated an existing pulmonary allergic inflammation; and (c) the
inflammatory and irritant responses to limonene, ozone or their
reaction products differed between allergic and nonallergic mice.
Standard mouse models of airway irritation based on head-out ple-
thysmography (Alarie 1973; Nielsen et al. 1999; Vijayaraghavan et al.
1993) and airway allergy to the model allergen ovalbumin (OVA)
(Kumar et al. 2008) were used to test the hypotheses.
Methods
Animals
Forty inbred BALB/cJ mice (female, 3- or 5-week of age) were
purchased from Taconic M&B (Ry, DK) and acclimatized for 3 or
1 week, respectively. All cages were furnished with Lignocel
(Brogaarden, DK) bedding material, gnaw sticks and transparent
red plastic nesting houses. The photoperiod was from 6 AM to
6 PM, and temperature and mean relative humidity in the animal
room were 20–22 C and 37–57%, respectively. Cages were sani-
tized twice weekly. Food (Altromin no. 1324, Altromin, Lage, DE)
and potable municipal tap water were available ad libitum.
Mice were randomly assigned to cages on arrival. Mice were
housed 3–4 per cage, thus 10 mice for each airborne exposure
were allocated to three cages. Of these 10 mice, five were sham-
and five OVA-sensitized and these mice were evenly distributed
in the three cages to eliminate any cage effects. Thus, 1–2 na€ıve
and 1–2 allergic mice were housed together. For practical reasons,
the limonene and ozone–limonene groups were sensitized and
exposed two weeks following the air and ozone groups, but all
mice were 6-week of age when entering the experiment. Mean
body weight was 17.5 and range of group means was 16.8–18.1 g
at Day 1 and did not differ between groups.
Treatment of the animals followed procedures approved by
The Animal Experiment Inspectorate, Denmark (Permissions no.
2006/561-1123-C3 and 2012 15 2934 00616-C1). All experi-
ments were performed by trained personnel and conformed to the
Danish Regulations on Animal Experiments (LBK nr. 474 af
15/05/2014 and BEK nr. 88 af 30/01/2013) that includes guidelines
on care and use of animals in research. Anesthesia was not used
during any airborne exposures because the bioassay depended on
spontaneously breathing animals. Animals were weighed on Days
1, 22, 26, 28 and 30.
Chemicals and anesthesia
Chicken egg ovalbumin (OVA, Grade V) was purchased from
Sigma (St. Louis, MO) and used without further purification. The
Al(OH)3 adjuvant (Alhydrogel) was obtained from Brenntag
Biosector, Denmark. R-(þ)-Limonene (99%) was bought from
Fluka (Sigma). For terminal anesthesia, ZRF cocktail containing
3.3mg zolazepam/mL, 3.3mg tiletamine/mL, 0.5mg xylazine/mL
and 2.6 lg fentanyl citrate/mL was administered intraperitoneally
at a nominal dose of 0.1mL/10 g body weight.
Generation and characterization of test atmospheres
OVA aerosols were generated by a PARI LC STAR nebulizer
(PARI GmbH, Germany) and the airborne concentration of
allergen determined gravimetrically as previously described
(Hansen et al. 2007). Generation and characterization of ozone,
limonene vapor and reaction mixtures of ozone and limonene
have been described previously (Clausen et al. 2001; Wolkoff
et al. 2008). In brief, ozone was generated by ultraviolet light
photolysis of oxygen (O2) and transferred at 50mL/min
through a stainless-steel tube to a 5 m polyethylene reaction
flow tube (ID¼ 2.5 cm) and diluted with an airflow of 17.7 L/
min dry medical grade air. Limonene vapor was generated by
passing nitrogen at 0.5 L/min through a 2-L glass thermostated
flask at 30 C with limonene (55mL) and transferred upstream
by a 1/4’’-Teflon tube (84 cm) to a 500-mL flask at ambient
temperature to trap condensed limonene before entering the
reaction flow tube in a 1/8-inch Teflon tube (length 84 cm). The
reaction flow tube was connected to a glass tube at the exposure
chamber inlet and the total flow adjusted to 18.2 [±0.1] L/min
in all experiments. This resulted in an 16 sec aged reaction
mixture in the exposure chamber where >95% of ozone was
consumed, leading to <0.03 ppm residual ozone in the reaction
mixture reaching the exposure chamber.
All experiments were carried out at 27 C, 1% relative
humidity, and 21% O2 content. Limonene and ozone concentra-
tions were monitored directly by a calibrated photoionization
detector (ppbRAE, RAE systems Inc., San Jose, CA) and a photo-
metric ozone analyzer (Model 400, API, Inc., San Diego, CA),
respectively. In addition, limonene was sampled on Tenax TA
60–80 mesh adsorbent tubes (200mg) using a sample volume of
50mL (gas-tight syringe) and a sampling time of  30 sec. Two
samples were taken twice during exposure in addition to samples
of the background levels before and after exposure, respectively.
Tubes were analyzed by thermal desorption–gas chromatogra-
phy–mass spectrometry (TD–GC–MS) as described previously
(Norgaard et al. 2014). We previously characterized similar limo-
nene–ozone reaction mixtures and determined the levels of for-
maldehyde (Wolkoff et al. 2008).
Aerosol number size distribution spectra were measured by a
Fast Mobility Particle Sizer (FMPS model 3091, TSI Inc.,
Shoreview, NM). The FMPS measures aerosols in the size range
from 5.6–532 nm, with a time resolution of 1 sec. Sample air to
the FMPS was diluted 1:10.
Exposure protocol
The experiment was performed as a 2 4 factorial design with
animals allocated to 1) OVA or sham sensitization and 2) expos-
ure to air (AIR), 2 ppm ozone (O3), 40 ppm limonene (LIM) or a
mixture of ozone and limonene that forms ozone-initiated limon-
ene reaction products (MIX). Table 1 depicts the exposure proto-
col. Half the mice were sensitized subcutaneously (SC) with 1 lg
OVA in 270 lg Al(OH)3 on Day 1 and received a SC booster
with 0.1 lg OVA on Day 15 (in bolus of 0.1mL 0.9% saline). On
Days 23 and 26, these mice were placed in body plethysmographs
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and exposed head-out only to 1% OVA solution for 20min. The
other half of the mice went through sham procedures; sham-
immunization with Al(OH)3 and 0.9% sterile saline and exposed
to aerosols of saline. A blood sample was collected by facial vein
puncture on Days 0 and 26. On Days 27, 28, and 29, the na€ıve
and allergic mice were placed in body plethysmographs and
exposed head-out for 60min to airborne exposures (AIR, O3,
LIM, or MIX). On Day 30, the mice were anaesthetized with ZRF
cocktail. Blood was collected by heart puncture, bronchoalveolar
lavage (BAL) of the whole lung was performed and the left lung
was frozen at 80 C.
Collection of respiratory parameters
Notocord Hem (Notocord Systems SA, Croissy-sur-Seine, France)
data acquisition software was used to collect respiratory parame-
ters. The acquisition program calculates for example the breathing
frequency (breaths/min), tidal volume (VT, mL), time from end
of inspiration until the beginning of expiration, termed time of
brake (TB, ms) and time from end of expiration until beginning
of the next inspiration, termed time of pause (TP, ms).
Stimulation of the trigeminal and vagal nerve endings causes
increases in TB and TP, which are markers of sensory and lower
airway irritation, respectively. Rapid shallow breathing (RSB) is
another reflex change in respiration due to pulmonary irritation.
Comprehensive descriptions of the breathing parameters and their
analyses have been made elsewhere (Alarie 1973; Vijayaraghavan
et al. 1993; Nielsen et al. 1999).
Assessment of acute respiratory effects during airborne
exposures
A short period was allowed for the animals to settle down and a
stable baseline to be reached as recommended (ASTM 1984).
Then, a 15-min baseline period was recorded for each mouse
while inhaling laboratory air. The exposure period (20min for
allergen challenge and 60min for airborne exposure) was followed
by a 15-min recovery period in which the mice were exposed to
laboratory air. To assess exposure-related effects, the respiratory
parameters during exposure were compared to baseline levels, that
is, each mouse served as its own control. For each mouse, mean
values of each minute during the experiment were calculated.
Airway irritation was evaluated during the airborne exposures on
Days 27–29. For each mouse, the mean value of the 20–29min
and 51–60min periods was calculated for the different respiratory
parameters. Thus, individual means of the periods were used in
the statistical analyses. This strategy was based on the expected
effects of ozone and the reaction products on airway irritation
(Nielsen et al., 1999; Clausen et al., 2001). The baseline values of
the individual mice did not differ significantly on Day 27–29
(data not shown). To capture a potential cumulative effect, the
data presented are from Day 29 only. Sensory irritation data from
this mouse bioassay is highly predictive of sensory irritation in
humans (Kuwabara et al. 2007; Schaper 1993).
Detection of OVA-specific antibodies in serum
Sera collected on Days 0, 26 and 30 were diluted 1:10, 1:300 and
1:300, respectively, and analyzed for OVA-specific IgE using an
in-house enzyme-linked immunosorbent assay (ELISA). Day 30
serum was also diluted 1:2000 and analyzed for OVA-specific
IgG1 using an in-house ELISA. Maxisorb microtiter plates (Nunc,
Roskilde, DK) were coated with 2lg/mL rat anti-mouse IgE (LO-
ME-3) or rat anti-mouse IgG1 (LO-MG1-13) (both, Life
Technologies, Carlsbad, CA) in 0.05 M carbonate/bicarbonate buf-
fer [pH 9.6]), followed by incubation for 1 h at room temperature
(RT) and thereafter at 4 C overnight. After washing with wash
buffer (50mM Tris/HCl þ0.05% Tween-20), the plates were
blocked with 3% skimmed milk powder in Milli-Q water and
incubated for 1 h at RT. After washing, 100 lL diluted sera was
added into duplicate wells and the plates were incubated for 1 h
at RT.
To assess IgE, wells were washed with buffer, 3 lg/mL biotin-
conjugated OVA (Nordic Biosite, DK) was added, and the plates
then incubated 1 h at RT. After another washing, poly-horseradish
peroxidase (HRP)–streptavidin (Life Technologies; 1:40 000 dilu-
tion) was added to each well and the plates incubated for another
1 h at RT. To assess IgG1, the wells were washed, treated with
100 lL HRP-conjugated OVA (AbD Serotec, Oxford, UK; 1:300
dilution in wash buffer) and then incubated for 1 h at RT. After a
final wash, all wells received 100 lL stabilized chromogen TMB
(Thermo Fisher Scientific, Waltham, MA)/well and then were
incubated for 15min before addition of 50 lL 2M H2SO4 stop
solution to each well. Optical density of all wells was then meas-
ured at 450 nm in an Epoch microplate reader (BioTek,
Winooski, VT). Standard curves were generated from duplicates
of diluted mouse antiovalbumin IgE (clone 2C6, AbD Serotec) or
diluted OVA-specific IgG1 (antiovalbumin antibody [F2-3.58],
Kerafast, Boston, MA) that had been included on each plate.
From these curves, values of the levels of each antibody in a given
sample were extrapolated. The detection limits of the ELISAs
were 60 ng IgE/mL and 1250 ng IgG1/mL.
Evaluation of inflammation in bronchoalveolar lavage fluid
(BALF)
BALF was collected by flushing the lungs three times each with
0.8mL ice-cold saline solution. Cells from the pooled fluids were
isolated by centrifugation (400  g, 10min, 4 C), resuspended in
100 lL HAMF12 and the supernatant then placed at 80 C for
later analyses. The total number of cells [including live and dead;
data not shown] was then determined using a Nucleocounter
NC-900-004 (ChemoMetec, Allerød, Denmark). The collected
cells were then spun onto cytospin slides that were then stained
Table 1. Exposure protocol and overview over statistical main effects, exposure groups and tissue/data collection.
Day 1 Day 15 Day 23, 26 Day 27–29 Day 30
Main effect ‘‘Sensitization’’ Main effect ‘‘Airborne exposure’’
Subcutaneous injection:
– ovalbuminþ Al(OH)3 (allergic)
or
– salineþ Al(OH)3 (na€ıve)
Subcutaneous injection:
– ovalbumin (allergic)
or
– saline (na€ıve)
Inhalation (20min aerosol):
– 1% OVA (allergic)
or
– saline (na€ıve)
60min inhalation:
– air (AIR) or
– ozone (O3) or
– limonene (LIM) or
– ozone/limonene (MIX)
Blood sample Blood sample Day 26 Plethysmography Blood/organ collection
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with May-Gr€unwald/Giemsa as described in Hansen et al. (2013).
Macrophages, lymphocytes, neutrophils and eosinophils were dif-
ferentially counted using a light microscope. A total of 200 cells/
slide was evaluated.
Surfactant protein D (SP-D) in BALF and serum
BALF supernatants were shipped from Copenhagen to Odense on
dry ice. Measurement of SP-D levels were done using a sandwich
ELISA as previously described (Hansen et al. 2008), taking
advantage of mouse-specific monoclonal antibody. Sera were
diluted 1:4 and BALF supernatants were diluted 1:50–1:500,
depending on the SP-D concentrations present. Measures were
carried out in triplicate. The detection limit of the ELISA was
5 ng SP-D/mL.
Lung tissue homogenization and determination of protein,
HO-1 and cytokines
Lavaged lung tissues were homogenized according to Viscardi
et al. (2006). A sample of approximately 100mg frozen lung
tissue/mouse was homogenized in 700 lL of 150mM NaCl/2mM
Tris [pH 7.5] solution containing 0.5% Triton-X and protease
inhibitors (P8340, Sigma). All homogenized lysates were incubated
at 4 C for 15min (with gentle rocking) and then centrifuged for
10min (13 000 g, 4 C). The resulting supernatants were isolated
and stored as aliquots at 20 C until analysis. A BCA protein
assay kit (Pierce, Rockford, IL) was used to assay protein content
in the lysates and BALF.
Heme oxygenase-1 (HO-1) levels were measured with an
ImmunoSet HO-1 (mouse) ELISA (Enzo Life Sciences,
Farmingdale, NY) according to manufacturer instructions. In
brief, wells were coated with capture antibody at RT overnight
and washed with blocking buffer before standards and aliquots
containing 100 lg lysate protein were transferred to each well.
Following subsequent washes, wells were incubated with detection
antibody and HRP conjugate. TMB substrate was added for color
development that was stopped by addition of 1 M HCl.
Background signal was determined by including a blank sample
with just the assay buffer and the analysis was carried out in
duplicate. All wells had their absorbance values measured at
450 nm in the Epoch microplate reader. The detection limit of the
ELISA was 96 pg HO-1/mL.
Levels of interleukin (IL)-5, IL-10, tumor necrosis factor (TNF)-
a and interferon (IFN)-c were determined by analyzing the content
in 100 lg lysate protein using a BD CBA Flex Set assay on a BD
Accuri flow cytometer (BD Biosciences, San Jose, CA).
Statistical analyses
BALF cell data and some respiratory parameters were log-trans-
formed to obtain homoscedasticity and normal distribution of the
residuals. Data were analyzed by two-way analysis of variance
(ANOVA) with sensitization (na€ıve, allergic) and airborne expos-
ure (AIR, O3, LIM, MIX) as fixed factors (Table 1). A Tukey’s
post hoc test was performed in cases when a significant main
effect of airborne exposure or a significant interaction effect were
found. In cases of a significant interaction, only relevant post hoc
comparisons are shown in figures, that is, comparisons between
the four allergic and four naive groups are not shown (e.g. na€ıve
LIM compared with allergic AIR, LIM, MIX or O3 groups). A p
value < 0.05 was considered statistically significant. Means ± SEM
are shown in the figures if not otherwise noted. The means (M)
of the compared groups are also given in the text when significant
differences were seen.
Results
Characterization of aerosols and gases
The mean (± SD) air concentrations of the 1% OVA feeding solu-
tion was based on the gravimetric measurements calculated to 65
[± 8mg] OVA/m3 air. We (Hansen et al. 2007) previously esti-
mated that >50% of the inhaled OVA aerosol is deposited in the
respiratory tract. This amounts to 47 lg OVA during the
two OVA challenges (for calculation method, see Hansen et al.
2007).
For the groups of mice exposed to limonene or ozone alone,
the concentrations were 40.0 [±2] and 2.0 [±0.3] ppm (mean
±95% CI), respectively. These were also used as initial concentra-
tions for the MIX group where the residual limonene and ozone
were measured to 34 [±2] and < 0.03 ppm, respectively. Particle
number concentration (measured during the presence of mice)
was; for pure air < 500 cm3, but around 1000 cm3 during ozone
and limonene exposure. The number concentrations for the limo-
nene–ozone reaction mixture varied slightly in the range
1.3–1.5 107 cm3 during the exposure. By fitting log-normal dis-
tribution to the averaged number size distribution spectrum, a
geometric mean particle size 29.3 nm with a geometric standard
deviation (rg) of 1.43 was obtained.
Animal weights
Mean group weights of the mice did not differ at Day 1 and the
sensitization procedures did not affect weight gain measured at
Day 26 (range of group mean¼ 18.6–20.5 g). Due to the daily
restraining from Days 26-29, mice lost 5.4% weight (range of
group weight means on Day 30¼ 17.5–19.4 g), but this was
not significantly affected by either sensitization or airborne
exposure.
Sensory irritation differed between na€ıve and allergic mice
exposed to ozone and to the reaction mixture
The sensory irritation response at 20–29min (indicated from spe-
cific marker TB elongation; Figures 1(A) and 1(B)), was only sig-
nificantly affected by airborne exposure (p¼ 0.035). A post hoc
analysis of the group means revealed that only the AIR
(M¼ 130%) and O3 (M¼ 186%) groups differed significantly
(p¼ 0.035) (Figure 1(A)). Thus, ozone caused sensory irritation in
both na€ıve and allergic mice, but the maximal response appeared
to be reached faster in na€ıve compared to allergic mice. Although
TB was elongated in the MIX groups compared to the AIR
groups, this was not significant at 20–29min (Figure 1(B)).
At 51–60min, a significant interaction effect was found
(p¼ 0.007) and all eight groups compared by post hoc testing. At
this time point, sensory irritation had disappeared in naive O3
mice; thus, irritation differed significantly between na€ıve O3
(M¼ 93%) and allergic O3 (M¼ 208%) mice (Figure 1(A), post
hoc, p¼ 0.011). Also at 51–60min, the sensory irritation was sig-
nificantly larger in na€ıve MIX (M¼ 238%) mice compared with
both na€ıve (M¼ 134%) and allergic (M¼ 128%) AIR animals
(Figure 1(B), post hoc na€ıve MIX vs. na€ıve AIR; p¼ 0.027). The
allergic MIX (M¼ 213%) group did not differ significantly from
the two AIR groups or from the na€ıve MIX group.
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Lower airway irritation differed between na€ıve and allergic
mice exposed to ozone
Pulmonary irritation may be observed from the RSB response
characterized by an increase in breathing frequency and a
decrease in VT. The LIM and MIX exposures did not induce
pulmonary irritation as seen from the breathing frequency
(Supplementary Figure 1(A)). At 20–29min, an effect on VT
was not observed in any of the groups (Figure 1(C)). Looking at
VT at the end of the exposure period (51–60min), a significant
interaction effect was found (p¼ 0.001). Comparing the groups
revealed that a reduction of VT was observed only in na€ıve O3
mice (Figure 1(C), post hoc na€ıve O3 vs. all other groups, p< 0.
05) indicating a shallow breathing pattern. The means of the
groups in Figure 1(C) are: na€ıve O3 (M¼ 72%), allergic O3
(M¼ 101%), na€ıve AIR (M¼ 99%), allergic AIR (M¼ 96%). At
the same time, the breathing frequency increased nonsignifi-
cantly with 14% relative to the AIR groups (Supplementary
Figure 1(A)). TP, another marker of pulmonary irritation was
not affected in any of the groups (Supplementary Figure 1(B)).
The minute volume per gram body weight decreased mainly in
the MIX and O3 groups (Table 2). The statistical analysis
showed a significant main effect of airborne exposures during
the exposure time 51–60min, and post hoc analyses revealed
that only the O3-exposed mice had significantly lower minute
volume/gram compared to the AIR- and LIM-exposed mice.
OVA-specific antibodies in serum
Before the primary sensitization, no OVA-specific IgE was
detected in serum. Serum was collected before the last OVA
challenge (Day 26) and at the end of the experiment (Day 30);
there was a significant effect of sensitization at Day 26, where
the M of na€ıve and allergic mice were 5 and 50 ng/mL, respect-
ively (Figure 2(A)) On Day 30, the group means of na€ıve
(M¼ 5 ng/mL) and allergic (M¼ 202 ng/mL) mice also differed
significantly (Figure 2(B)). IgE levels at Day 26 did not differ in
the AIR, O3, LIM and MIX groups, indicating comparable
immune responses in the groups before airborne exposures. The
following 3 d of O3, LIM, or MIX exposures were without
significant effects on OVA-specific IgE levels, although they
appeared lower in the allergic LIM and MIX mice. OVA-specific
IgG1 was only affected significantly by sensitization (Figure
2(C)), with mean values of 2606 and 24 459 ng/mL in na€ıve and
allergic mice, respectively.
Allergic inflammation was reduced in particular by the
ozone/limonene reaction mixture (MIX)
Whereas no inflammation was observed in the sham-sensitized
mice, significantly higher numbers of macrophages (M¼ 119 339
vs. 214 892 cells; na€ıve vs. allergic, respectively), eosinophils (38
999 vs. 1 477 746 cells), lymphocytes (1887 vs. 78 754 cells) and
neutrophils (1109 vs. 3684 cells) were observed in the allergic
mice (Figure 3, significant main effect of sensitization). A signifi-
cant interaction effect was found for the total number of eosino-
phils; in allergic mice, numbers were significantly decreased by
the MIX exposure (M¼ 863 484 cells) compared to the O3 expos-
ure (1 919 820 cells) (Figure 3(A)). A significant main effect of
airborne exposure was found for the number of lymphocytes and
neutrophils, that is, in both na€ıve and allergic mice, MIX exposure
(16 569 cells) reduced the numbers of lymphocytes (compared to
LIM [58 905 cells] and O3 [47 025 cells], p¼ 0.04 and 0.032,
respectively, Figure 3(B)). The MIX exposures (M¼ 23 cells) also
reduced neutrophil numbers (compared to AIR [4960 cells] and
O3 [3784 cells], p¼ 0.013 and 0.023, respectively, Figure 3(C)) in
both allergic and na€ıve mice.
Elevated protein levels in BALF in allergic compared to na€ıve
mice were in agreement with an increased inflammation, but
these levels were also affected by the airborne exposures (Figure
3(E)). In both na€ıve and allergic mice, LIM (M¼ 230 lg/mL) and
MIX (M¼ 242 lg/mL) exposures significantly reduced protein
levels in comparison to those seen in the O3 group (M¼ 323 lg/
mL) (p¼ 0.02 and p¼ 0.03, respectively).
Levels of TNFa, IFNc and IL-10 in lung homogenates were
not significantly affected (Supplementary Figure 2). However,
IL-5 levels were significantly increased in allergic compared to
na€ıve mice (M¼ 7.0 vs. 2.7 pg/mL, Figure 3(F)). Further, post
hoc analysis of the significant main effect of airborne exposure
revealed that IL-5 levels in the LIM groups (M¼ 3.6 pg/mL)
were reduced relative to those in the AIR groups
(M¼ 6.7 pg/mL) (p¼ 0.029).
Figure 2. Na€ıve and allergic mice were exposed to AIR, O3, LIM or MIX for 60min on Days 27–29. OVA-specific IgE was measured in serum (A) before (Day 26) and (B)
after (Day 30) exposure. (C) Day 30 OVA-specific IgG1. Bars represent mean± SEM of 5 mice/group. Results of two-way ANOVA are given above figures.
Table 2. Effects on minute volume per gram on day 29 during the exposure
period 51–60min.
Airborne exposure
(both naive and allergic mice)a
Minute volume pr. gram as
% of baseline (mean and SD) Post hoc analysesb
AIR 82.5 (4.7) cp¼ 0.009
O3 70.7 (10.8)
LIM 82.9 (6.7) cp¼ 0.007
MIX 76.7 (6.9)
aStatistical analysis did not find a significant main effect of sensitization or a
significant interaction effect, why mean values of both naive and allergic mice
are shown.
bSignificant main effect of airborne exposure was found at p¼ 0.003.
cValue significantly different from O3.
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SP-D in BALF and serum and HO-1 in lung tissue
homogenates
In their BALF, allergic mice had higher levels of SP-D than na€ıve
mice (M¼ 4685 vs. 902 ng/mL, Figure 4(A)). Post hoc analyses of
the significant interaction effect revealed that in the allergic mice,
the LIM (M¼ 2342 ng/mL) and MIX (M¼ 2312 ng/mL) groups
had significantly lower SP-D levels compared to both the AIR
(M¼ 2941 ng/mL) and O3 (M¼ 3405 ng/mL) groups. SP-D levels
in serum were near the detection limit and no significant differen-
ces were observed (M¼ 6 ng/mL for both na€ıve and allergic
mice).
The levels of HO-1 were measured in lung homogenates as a
marker of oxidative stress (Valacchi et al. 2004). The allergic mice
Figure 3. Na€ıve and allergic mice were exposed to AIR, O3, LIM and MIX for 60min on Days 27–29 and total number of (A) eosinophils, (B) lymphocytes and (C) neutro-
phils in BALF analyzed on Day 30. (D) Protein levels in BALF and (E) IL-5 levels in lung homogenates on Day 30. Bars represent mean± SEM of 5 mice/group. Results of
two-way ANOVA are given above figures. Post hoc analyses of significant main and interaction effects are described in the text. *indicates a significant effect at p< 0.05.
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had significantly increased levels of HO-1 compared to na€ıve
mice (M¼ 10.7 vs. 5.6 ng/g) and this was independent of airborne
exposure (Figure 4B).
Discussion
Effects of ozone and ozone–limonene reaction products on
sensory/pulmonary irritation
In contrast to the current findings, ozone-induced sensory irrita-
tion has not been observed previously in mice (Nielsen et al.
1999). Ozone is generally not a potent sensory irritant as the
threshold is 5 ppm for trigeminal nerve activation in rats (Kulle &
Cooper 1975). Interestingly, sensory irritation persisted only in
allergic O3-exposed mice. This indicates that the upper airways
could be more susceptible to irritation due to the inflammatory
condition. During the recovery period, the effect of ozone on TB
slowly disappeared, suggesting that the sensory nerve activation is
not due to a simple reversible receptor binding.
Because the ozone concentration was negligible in the MIX
group (< 0.003 ppm), oxidation reaction products were not
expected to be generated in the nasal mucosa. A major part of the
irritation caused by the reaction mixture is due to formaldehyde,
which is highly water soluble (Wolkoff et al. 2008). In the MIX
groups, the sensory irritation was significant in na€ıve mice as pre-
viously reported (Clausen et al. 2001), but not in allergic mice.
Further, the maximal TB elongation due to ozone appeared to
occur faster in na€ıve compared to allergic mice. Overall, this
suggests that increased mucus content of the airway (as expected
in allergic mice (Larsen et al. 2010) may retard sensory irritants.
In contrast, allergic mice in the current study appeared to be
protected from the pulmonary irritation response induced by
ozone. We have previously shown a 50% reduction of VT (Nielsen
et al. 1999) by 2 ppm ozone, which is in fair agreement with the
30–40% in the na€ıve mice in the present study. The sensory irrita-
tion response (TB) would later disappear or be masked by the
occurrence of pulmonary effects in the naive mice. Thus, it may be
speculated that airway inflammation protects the allergic mice from
pulmonary irritation induced by ozone. We previously showed that
sensory irritation of formaldehyde was more severe in na€ıve com-
pared to allergic mice; this could be explained by a scavenging
effect of the increased mucus layer in allergic airways (Larsen et al.
2013). Opposite to formaldehyde, ozone reaches the lower airways
due to its low water solubility. However, in an analogy with the
scavenging of formaldehyde by the nasal mucus, ozone may be
scavenged by mucus in the inflamed airways. OVA-sensitized mice
have more mucus (Larsen et al. 2010), which is supported by their
higher BALF protein content. A study by Schelegle and Walby
(2012) indicated a more rapid onset of the VT decrease (and thus
pulmonary irritation response) in na€ıve compared to allergic rats,
which is in overall agreement with the current results, where only
na€ıve mice had a decrease in VT during the 1-h exposure. After
2 h (out of a total of 8 h) of exposure to 1 ppm ozone, those investi-
gators found the RSB response to be aggravated in allergic relative
to na€ıve rats; therefore, prolonged exposure may be necessary to
see an aggravating response in allergic animals.
In another study, C57Bl/6 mice were exposed for 1 h to 1 ppm
ozone 3 h after an OVA challenge. Pulmonary measurements by
intubation showed a decreased minute ventilation in allergic, but
increased minute ventilation in control mice; this was interpreted
as allergic mice being more sensitive to ozone (Yamauchi et al.
2002). We did not observe differences in minute ventilation
between allergic and na€ıve O3 mice, but a decreased minute
volume in both groups. The decrease in O3-exposed na€ıve mice
could reflect occurrence of the RSB response, whereas the
decrease in in allergic mice exposed to O3 was driven by sensory
irritation, characterized by TB elongation, and thus, a decrease in
respiratory frequency. The major differences between the
Yamauchi study and the current one is that the latter used con-
scious spontaneously breathing mice in contrast to anaesthetized
and intubated mice in the former. Furthermore, the outcome may
depend on strain (Vancza et al. 2009; Wesselkamper et al. 2001).
A recent review of chamber studies concludes that no differences
in sensitivity were observed on FEV1 and airway resistance in
asthmatic and healthy subjects exposed to up to 2 ppm ozone
(Johansson et al. 2015), in agreement with the current study.
Effects of ozone and ozone/limonene reaction products on
allergic airway inflammation
It was hypothesized that inhalation of ozone, limonene, and
ozone-initiated limonene reaction products may aggravate or
Figure 4. Na€ıve and allergic mice were exposed to AIR, O3, LIM and MIX for 60min on Days 27–29. Levels of (A) SP-D in BALF and (B) HO-1 in lung homogenate were
measured on Day 30. Bars represent mean± SEM of 5 mice/group. Results of two-way ANOVA are given above figures. Post hoc analyses of significant interaction effect
in (A) is shown in figure by a * indicating a significant difference at p< 0.05.
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attenuate allergic airway inflammation. Our mouse asthma model
exhibited classical features of airway allergy, such as elevated aller-
gen-specific IgE, eosinophil-dominated inflammation and
increased protein and IL-5 content in the lungs.
When allergic mice were exposed to 2 ppm ozone on three
consecutive days, ozone did not aggravate allergen-specific anti-
body production or existing airway inflammation. In contrast, 4 h
of exposure to 0.1 ppm ozone did not induce airway inflammation
in itself, but did exacerbate eosinophilia, when preceding airway
allergen challenge (Depuydt et al. 2002). Kierstein et al. (2008)
exposed Aspergillus-sensitized mice for 2 h to 3 ppm ozone 3 days
after allergen challenge and found eosinophil numbers were ele-
vated compared to air-exposed allergic mice, but other parameters
did not differ from ozone-exposed na€ıve mice. Several weeks of
repeated ozone/allergen (compared to air/allergen) exposure
increased the anaphylaxis reactivity in Swiss-Webster mice with a
dose–response relationship from 0.10 (no-observed effect level) to
0.24 ppm ozone (Osebold et al. 1988). Thus, some animal studies
have demonstrated exacerbation of allergy under circumstances of
extended ozone exposure. One human study showed that ozone
inhalation increased sputum markers of inflammation in atopic
subjects with asthma compared to in atopic subjects without
asthma (Hernandez et al. 2010). However, only few controlled
studies have demonstrated asthmatic subjects to be more sensitive
in terms of inflammatory markers (Johansson et al. 2015).
Few animal studies have investigated airway effects of
ozone–terpene oxidation products apart from sensory irritation.
Sunil et al. (2007) investigated pulmonary pathology in rats after
3 h of exposure to a mixture of 0.8 ppm ozone and 6 ppm limon-
ene and found increased levels of TNFa and markers of oxidative
stress, but no inflammatory cells in BALF. Although limonene
levels were much lower than in the present study, all ozone is
expected to be removed and the changes in biomarkers thus
related to generation of reaction products. Rohr (2001) found no
pulmonary inflammation in mice after single or repeated expo-
sures to reaction products from a mixture of 862 ppm isoprene
and 3.23 ppm ozone. No airway inflammation was observed in
mice after 10 days of repeated exposure to ozone-limonene reac-
tion mixtures based on 52 ppm limonene and initial ozone con-
centrations of 0.5, 2.5 or 3.9 ppm (Wolkoff et al. 2012). The
resulting residual ozone concentration was < 0.01 ppm ozone. The
present study supports the above findings that the ozone-terpene
reaction mixture does not induce inflammation in itself. Further,
aggravation of allergic airway inflammation was not observed. A
chamber study comparing subjects with or without asthma found
a lower perceived nose and throat sensory irritation in asthmatic
subjects, but not in the eyes, when exposed to ozone/limonene
reaction products; however, other responses were inconclusive
(Fadeyi et al. 2015).
Anti-inflammatory effects of limonene and ozone/limonene
reaction products
Lastly, it was hypothesized limonene alone could have an alleviat-
ing effect on allergic inflammation. In murine splenocytes, limon-
ene is suggested to have anti-inflammatory and T-helper cell
(TH)-2-stimulating properties mainly via promoting IL-10 secre-
tion (Ku & Lin 2013) and limonene has been shown to possess
antioxidant properties (Fraternale et al. 2007; Roberto et al. 2010).
However, dampening of inflammatory responses was more evi-
dent in the MIX compared to the LIM groups and in particular
relative to the O3 mice. This could not be explained by differences
in minute ventilation, because it did not differ between these
groups. Limonene did not decrease cellular infiltration signifi-
cantly, but decreased protein, IL-5 and SP-D. In contrast, inhal-
ation of the reaction mixture decreased inflammatory cells,
protein, and SP-D levels in the BALF. The tendency to lower IL-5
production supported the anti-inflammatory effects.
The observed low attenuation of cellular infiltration by limon-
ene may require a larger group size or prolonged limonene expos-
ure to detect significant effects. The Keinan group used 7–30 days
of exposure to 125 ppm limonene to show decreases in peribron-
chial inflammation and BALF neutrophils in sensitized rats and
BALB/c mice (Bibi et al. 2015; Keinan et al. 2005). Hirota et al.
(2012) used limonene inhalation exposures for 30 days concurrent
with allergen sensitization of BALB/c mice and showed clear
decreases in antibody production, airway inflammation and cyto-
kine levels. Our previous subchronic inhalation study indicated an
anti-inflammatory effect of limonene, but the ozone/limonene
exposure most evidently decreased inflammation, although an
IgE-promoting effect also was noted (Hansen et al. 2013).
Limonene that has not reacted with ozone is still the dominating
VOC present in the reaction mixture. Thus, the anti-inflammatory
effect of the reaction mixture may be due not only to the excess
limonene, but also due to other oxidation products.
Upregulation of pulmonary SP-D is linked to both chronic
obstructive pulmonary disease and asthma (Sorensen et al. 2007).
Post-translational modifications of SP-D occur due to reactive
oxygen species (ROS) exposure, which enhances the pro-inflam-
matory signaling of SP-D (Ledford et al. 2014). Thus, the signifi-
cantly lower content of SP-D in BALF of the allergic LIM and
MIX mice may reflect lower requirement for protection against
oxidative stress. Also, a feedback regulation between eosinophils
and SP-D occurs in allergic inflammation (Ledford et al. 2014);
this was reflected in particular in the MIX group in the present
data set. Overall, this study supports SP-D as being a marker of
oxidative stress and/or of immunomodulation.
In several cell and tissue models, HO-1 is upregulated in
response to cellular stress (Ryter et al. 2006), including exposures
to environmental pollutants such as ozone (Sunil et al. 2013;
Valacchi et al. 2004), or when cytoprotective responses are
required (Ryter et al. 2006). Therefore, HO-1 was selected to
investigate whether antioxidant effects of limonene (and the reac-
tion mixture) could be detected. However, HO-1 was not differen-
tially expressed between the four airborne exposures. The
regulation of HO-1 is biphasic and as a response to oxidative
stress, HO-1 is upregulated within 6 h (Risom et al. 2003; Sunil
et al. 2013). At later time points (including in the lung), HO-1 is
involved in suppressing inflammation and initiating wound heal-
ing (Lee et al. 2009; Ryter et al. 2006), which may be the reason
for a comparable upregulation in the groups of allergic mice.
The present study noted a trend of decreased OVA-specific
IgE in the allergic LIM and MIX mice compared to in the AIR
mice. IgG1 levels were unaffected by airborne exposures. Isotype
switching to IgE occurs after IgG1, and thus, it may be speculated
that local IgE production may be affected by ongoing allergic
inflammation. In the allergic LIM and MIX mice, cytokine levels
and inflammatory markers were dampened, which eventually may
lead to less antigen being processed by antigen-presenting cells
(Lambrecht & Hammad 2015). Whether local antioxidant treat-
ment may lead to a reduction in antibody levels remains to be
confirmed, but limonene inhalation concurrent with allergen
exposure did decrease allergen-specific antibody levels in a mouse
model of airway allergy (Hirota et al. 2012). Until now, the main
focus of terpene–ozone reaction products has been in relation to
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adverse health effects. However, this study suggests that health
effects may be more complex.
Conclusions
Ozone and ozone/limonene reaction products exposures caused
significant sensory irritation, however, the reaction products only
in na€ıve mice. Allergic compared to naive mice appeared more
sensitive to upper airway irritation, but allergic mice were pro-
tected from the pulmonary irritation caused by ozone. This may
be ascribed to a scavenging effect of the mucus in the airways.
Surprisingly, the ozone-initiated reaction products were more
potent in attenuating airway inflammation than limonene itself.
Characterization of the mechanisms behind this requires further
studies. Overall, airway allergic responses were not exacerbated by
short-term exposure to the tested airway irritants. Our data on
ozone exposure are in general agreement with human chamber
studies not showing consistent differences between healthy and
asthmatic subjects.
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